Evidence map›Paper›PMID 36625869›Full record

ReviewEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2023

Multicentric study on surgical information and early safety and performance results with the Bonebridge BCI 602: an active transcutaneous bone conduction hearing implant.

Georg Sprinzl, Joseph Toner, Assen Koitschev, Nadine Berger, Thomas Keintzel, Thomas Rasse, Wolf-Dieter Baumgartner, Clemens Honeder, Astrid Magele, Stefan Plontke and 6 more

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04427033 (The BCI 602 BONEBRIDGE Post-Market Clinical Follow-up Study), which is not on this map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04427033 completednot on this map

The BCI 602 BONEBRIDGE Post-Market Clinical Follow-up Study

TypeobservationalSponsorMED-EL Elektromedizinische Geräte GesmbHRan2019 to 2024Enrolled52ConditionsHearing Loss, Hearing Loss, Conductive, Hearing Loss, Mixed, Hearing Loss, UnilateralArmsBone Conduction Implant
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Guideline
  2. Trial
  3. Patient-reported outcomes and speech-in-noise performance with OSIA versus other transcranial devices in unilateral and asymmetric hearing loss.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  4. Article
  5. Precise bonebridge implantation in challenging cases: a novel approach using virtual planning and electromagnetic navigation.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  6. The Bonebridge Active Bone Conduction Hearing Implant: Safety, Effectiveness and Outcomes Based on 355 Patients.Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2026
    Article
  7. Article
  8. A new active bone-conduction implant: surgical experiences and audiological outcomes in patients with bilateral congenital microtia.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  9. Article
  10. Role of early hearing aid experience in speech recognition in patients with bilateral congenital microtia following Bonebridge implantation: a retrospective cohort study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Georg SprinzlHals-Nasen-Ohren-Abteilung, Karl Landsteiner Privatuniversität für Gesundheitswissenschaften und Karl-Landsteiner Institut für Implantierbare Hörsysteme, Universitätsklinikum St. Pölten, Dunant-Platz 1, 3100, St. Pölten, Austria. georg.sprinzl@stpoelten.lknoe.at.ORCID http://orcid.org/0000-0003-4936-1424
Joseph Toner *Regional Auditory Implant Centre, Beech Hall Centre, Belfast, Northern Ireland, UK.
Assen KoitschevKlinik für HNO-Krankheiten, Plastische Operationen, Klinikum Stuttgart, Olgahospital, Stuttgart, Germany.
Nadine BergerKlinik für HNO-Krankheiten, Plastische Operationen, Klinikum Stuttgart, Olgahospital, Stuttgart, Germany.
Thomas KeintzelAbteilung für Hals-, Nasen-, Ohrenkrankheiten, Klinikum Wels-Grieskirchen, Wels, Austria.
Thomas RasseAbteilung für Hals-, Nasen-, Ohrenkrankheiten, Klinikum Wels-Grieskirchen, Wels, Austria.
Wolf-Dieter BaumgartnerAllgemeines Krankenhaus der Stadt Wien, Universitätsklinik für Hals-, Nasen- und Ohrenkrankheiten, Vienna, Austria.
Clemens HonederAllgemeines Krankenhaus der Stadt Wien, Universitätsklinik für Hals-, Nasen- und Ohrenkrankheiten, Vienna, Austria.
Astrid MageleHals-Nasen-Ohren-Abteilung, Karl Landsteiner Privatuniversität für Gesundheitswissenschaften und Karl-Landsteiner Institut für Implantierbare Hörsysteme, Universitätsklinikum St. Pölten, Dunant-Platz 1, 3100, St. Pölten, Austria.
Stefan PlontkeDepartment of Otorhinolaryngology, Head and Neck Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.ORCID http://orcid.org/0000-0002-5424-7688
Gerrit GötzeDepartment of Otorhinolaryngology, Head and Neck Surgery, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
Joachim SchmutzhardUniversitätsklinik für Hals-, Nasen- und Ohrenheilkunde Innsbruck, Medizinische Universität Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0001-5030-8132
Philipp ZelgerUniversitätsklinik für Hör-, Stimm- und Sprachstörungen, Medizinische Universität Innsbruck, Innsbruck, Austria.ORCID http://orcid.org/0000-0002-6543-7620
Stephanie CorkillRegional Auditory Implant Centre, Beech Hall Centre, Belfast, Northern Ireland, UK.
Thomas LenarzMedizinische Hochschule Hannover, Klinik und Poliklinik für HNO-Heilkunde, Hannover, Germany.ORCID http://orcid.org/0000-0002-9307-5989
Rolf SalcherMedizinische Hochschule Hannover, Klinik und Poliklinik für HNO-Heilkunde, Hannover, Germany.
Innsbruck Medical University · ATKlinikum Wels-Grieskirchen · ATMartin Luther University Halle-Wittenberg · DEMedizinische Hochschule Hannover · DEOlgahospital · DEUniversitätsklinikum St. Pölten · ATVienna General Hospital · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis European multicentric study aimed to prove safety and performance of the Bonebridge BCI 602 in children and adults suffering from either conductive hearing loss (CHL), mixed hearing loss (MHL), or single-sided sensorineural deafness (SSD).

methods33 patients (13 adults and 10 children with either CHL or MHL and 10 patients with SSD) in three study groups were included. Patients were their own controls (single-subject repeated measures), comparing the unaided or pre-operative to the 3-month post-operative outcomes. Performance was evaluated by sound field thresholds (SF), word recognition scores (WRS) and/or speech reception thresholds in quiet (SRT) and in noise (SNR). Safety was demonstrated with a device-specific surgical questionnaire, adverse event reporting and stable pure-tone measurements.

resultsThe Bonebridge BCI 602 significantly improved SF thresholds (+ 25.5 dB CHL/MHL/SSD), speech intelligibility in WRS (+ 68.0% CHL/MHL) and SRT in quiet (- 16.5 dB C/MHL) and in noise (- 3.51 dB SNR SSD). Air conduction (AC) and bone conduction (BC) thresholds remained stable over time. All adverse events were resolved, with none unanticipated. Mean audio processor wearing times in hours [h] per day for the CHL/MHL group were ~ 13 h for adults, ~ 11 h for paediatrics and ~ 6 h for the SSD group. The average surgical length was 57 min for the CHL/MHL group and 42 min for the SSD group. The versatility of the BCI 602 (reduced drilling depth and ability to bend the transition for optimal placement) allows for treatment of normal, pre-operated and malformed anatomies. All audiological endpoints were reached.

conclusionsThe Bonebridge BCI 602 significantly improved hearing thresholds and speech understanding. Since implant placement follows the patient's anatomy instead of the shape of the device and the duration of surgery is shorter than with its predecessor, implantation is easier with the BCI 602. Performance and safety were proven for adults and children as well as for the CHL/MHL and SSD indications 3 months post-operatively.

Indexed as

Brain-Computer InterfacesDeafnessHearing AidsHearing LossHearing Loss, Mixed Conductive-SensorineuralHearing Loss, SensorineuralSpeech PerceptionAdultBone ConductionChildHearingHearing Loss, ConductiveHumansMulticenter Studies as TopicTreatment OutcomeBonebridgeBone conductionBone conduction implantConductive hearing lossMixed hearing lossSingle-sided sensorineural deafnessTranscutaneous hearing implant

Identifiers

PMID36625869
PMCPMC9988757
OpenAlexW4315436488

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.